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CurrentIntraoperative seizures during awake craniotomy with cortical and subcortical mapping are a common
occurrence. Patients are routinely treated preoperatively with anti-convulsive medications to reduce seizure
occurrence. Historically these drugs have not been believed to signiﬁcantly affect awake craniotomy
procedures. We report a patient undergoing intraoperative mapping with differential response and seizure
occurrence based upon antiepileptic drug usage. A 43 year old female presented with history of seizures, right
sided hemiparesis, electrical sensations, and difﬁculty with language function. She was determined to have a
mass lesion involving the left frontal and temporal lobes and subsequently elected to undergo resection by
awake craniotomy with intraoperative mapping. A ﬁrst attempt at lesion resection was performed after a
missed dose of anti-convulsant medication (levetiracetam) and was subsequently aborted because of
repeated seizure activity. The threshold for seizure generation (1.75 mA) was observed to be signiﬁcantly
lower than expected. Therapy was begun with both levetiracetam and phenytoin prior to a second attempted
resection one week later. Thresholds for cortical motor response in the second operation were signiﬁcantly
higher than expected (N 9.0 mA), and no intraoperative seizure activity was observed. To our knowledge this
is the ﬁrst quantitative example of antiepileptic drugs affecting the current required for intraoperative
mapping. This case highlights the potential for higher current requirements in patients preoperatively
treated with high doses of antiepileptic drugs, as well as the importance of conﬁrming adequate dosage of
antiepileptic drugs in patients at an increased risk of seizure generation.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The increasing availability of functional magnetic resonance
imaging, cortical magnetoencephelography, and Diffusion Tensor
Imaging (DTI) has offered additional methods to pre-operatively
map brain function and the associated functional white matter tracts.
Despite these novel imaging techniques, awake craniotomy with
direct cortical and subcortical stimulation remains the gold standard
for brain mapping in order to identify which lesions or portions
thereof may be removed with minimal clinical sequelae. However,
unlike the aforementioned non-invasive imaging modalities, intraop-
erative seizures during an awake craniotomy with brain mapping are
a relatively common complication of the procedure, with reported
incidence as high as 32% [1,2]. From our experience seizures are more
commonly observed with higher levels of stimulation, although there
is no established threshold for seizure generation. Most seizures
are sporadic and quickly aborted, and prior studies show that these
intraoperative seizures rarely evolve into generalized seizures [1,3,4]., antiepileptic drug; GBM,
FOT 1062, Birmingham, AL
B.V. This is an open access article uResearch into this procedure has found the strongest correlation for
intraoperative seizures in patientswith a history of epilepsy, as well as
patients taking multiple antiepileptic drugs [4,5].
In order to reduce the occurrence and severity of intraoperative
seizures, antiepileptic drugs (AEDs) are routinely given preoperatively
even to patients who have not had seizures. Historically these drugs have
not been believed to have a signiﬁcant negative effect on awake
craniotomy procedures, although a recent review of 424 awake
craniotomy procedures reported that phenytoin was signiﬁcantly
associated with communication failures during cortical mapping [6].
Although it is commonly understood that abrupt discontinuation of AEDs
can lead to a transient period with a reduced seizure threshold, to our
knowledge therehavebeenno reportsdetailing theeffects of antiepileptic
drugs on the amount of current required tomap eloquent cortex in awake
craniotomies. We describe a case where antiepileptic use/disuse was
thought to be directly related to both the amount of current required to
elicit a motor response and the current needed to produce a seizure.
Case
We present the case of a 43 year old right-handed white female
who presented to us with a 3 month history of electrical sensations in
her right hand and right leg in addition to difﬁculty with word ﬁnding,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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was noted to have anxiety. The patient denied any history of seizure
activity. MRI demonstrated a ring-enhancing mass lesion in the
posterior aspect of the left frontal lobe with extension into the
superior posterior left temporal lobe and insula with surrounding
vasogenic edema. There was mass effect with mild effacement of the
lateral ventricle. Pre-operative MRI images are shown in Fig. 1. This
mass was biopsied stereotactically. The pathology specimen was
determined to be a glioblastoma multiforme (GBM). DTI was
performed and this demonstrated that the corticospinal tracts were
likely to be anteromedial to the lesion. The arcuate fasciculus,
however, appeared to be pushed superiorly via mass effect and was
in much closer proximity to and possibly invaded by the lesion. Due to
the proximity of eloquent cortex affecting language, motor, and
sensory tracts, the patient was advised to undergo an awake
craniotomy with intraoperative brain mapping and stealth guidance
and this was arranged for the ﬁfth day following her biopsy. She was
discharged on lorazepam 1 mg TID PRN for anxiety, dexamethasone
4 mg QID, and levetiracetam 500 mg BID four days prior to her awake
craniotomy. The levetiracetam was started on postoperative day 1 of
the stereotactic biopsy, so this discharge regimen would allow the
patient to take eight doses of levetiracetam before the surgery.
Surgical procedure and clinical course
An incision was fashioned based upon the location of the tumor.
An adequate cortical surface was exposed to map the frontal cortex
and associated language cortex. The location of the tumor was
conﬁrmed with the Stealth system and the proposed mapping sites
were reconﬁrmed. Intraoperative mapping was undertaken using 4–
5 s squarewave pulses at a frequency of 60 Hz. The area of anticipated
motor cortex was initially stimulated with 1 mA with no response.
Two milliamperes then was used over the motor cortex and this
produced tonic clonic movement that progressed to generalized
seizure activity, requiring irrigation with iced lactated ringer’s for
resolution (see Fig. 2). The current was decreased and the motor
cortex continued to show no response to stimulation with 1.5 mA,
while repeated attempts using 1.75 mA reliably caused the patient to
enter a generalized seizure, requiring iced lactated ringer’s irrigation
at each occurrence (see Figs. 2–4). Thus the decision was made to
close the craniotomy and consult with the epilepsy neurology service
to assist with institution of a superior preoperative AED regimen.
After the surgery, the patient's levetiracetam prescription was
increased to 1000 mg BID, and the patient was started on phenytoin.
The patient’s dexamethasone was continued at 4 mg QID. Interest-
ingly, after some questioning the patient admitted to being confusedFig. 1. Pre-operative MRI images: axial T2 ﬂair (left), axial T1 post-contrast (center), and coro
characteristic of glioblastoma multiforme. Due to the proximity of the tumor to the tempor
intraoperative mapping was recommended for resection of the lesion.by her preoperative instructions. It was determined that the patient
had taken her scheduled dose the evening prior to surgery, but had
omitted her dose the morning of surgery. The patient remained
neurologically stable, although she did experience some worsening of
her expressive aphasia as a result of the seizure activity. The patient
was transferred to the ﬂoor the next day, and discharged home on the
2nd postoperative day.
The patient returned to the hospital on the 7th postoperative day
for another attempt at resection; however, this time she had a
phenytoin level of 15.4 μg/ml and was taking an increased dosage of
levetiracetam. This awake craniotomy proceeded as anticipated with
a very different response to stimulation. As before, the motor cortex
was stimulated with 1 mA and this elicited no response. The current
was slowly increased and no motor response was seen until
stimulation with 9.0 mA. This current was observed to be the
threshold stimulation to elicit repetitive arm response. This same
current was then used to complete speech and motor mapping. The
procedure was successful in removing the vast majority of the tumor
with only a small residual that was adherent to the middle cerebral
artery. No intraoperative seizures were observed during this second
craniotomy for resection.
Discussion
This case demonstrates the unique ﬁndings of a patient undergo-
ing intraoperative cortical stimulation on two different AED regimens
only one week apart. Although exact levetiracetam levels are not
known, during the ﬁrst surgery the patient’s levels were likely lower
after missing her dose themorning of the procedure, while the second
surgery was performed with the patient on high dosage levetiracetam
and a therapeutic phenytoin level. The threshold for motor stimula-
tionwas observed to increase from 1.75 mA during the ﬁrst procedure
to 9.0 mA in the second procedure. Additionally, seizure activity was
initiated at 1.75 mA in the ﬁrst procedure, while stimulation at levels
up to 9.0 mA did not evoke seizure activity in the second procedure.
Although this effect might be taken for granted by those who
routinely pretreat their patients with AED's prior to intraoperative
brain mapping, this is the ﬁrst report of a quantitative increase in
seizure and motor stimulation thresholds as a result of varying
preoperative AED dosages in a single patient.
Phenytoin is a well-established anti-convulsant drug used to
prevent repetitive ﬁring of neurons and resulting generation and
spread of seizure activity. Although phenytoin’s mechanism of action
is not completely understood, it is proposed to inhibit sodium ﬂux
through voltage dependent sodium channels on the neuronal
membrane. This inhibition serves to stabilize membrane potentialnal T1 post-contrast (right). MRI illustrates edema, necrosis, and contrast enhancement
al and insular lobes of the patient's dominant hemisphere, an awake craniotomy with
Fig. 2. After stimulation with 2 mA, the patient produced tonic–clonic movement that progressed to generalized seizure. Iced lactated Ringer’s solution was used and the seizure was aborted.
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individual neurons against excessive ﬁring, phenytoin is able to
inhibit the spread of neuronal electrical activity, preventing localized
seizure foci from evolving into generalized seizures as seen in this
case. The antiepileptic effects of levetiracetam are believed to be due
to the drug’s ability to bind synaptic vesicle protein 2A. This protein
plays a role in exocytosis of neurotransmitter containing vesicles,
although the details of these interactions are not completely
understood. By modulating the axonal release of neurotransmitter,
levetiracetam has been shown to be protective against seizure activity
in a variety of epilepsy models, as well as effective in reducing
development of seizure kindling [7].
The quantitative difference in current required for cortical
mapping and initiation of seizure activity between the two attempted
resections one week apart suggests a difference in cortex excitability
potentially due to the presence of phenytoin and levetiracetam.
Missing a dosage of antiepileptic medication in a patient with
potential seizure foci may have resulted in a decreased seizure
threshold in the ﬁrst attempted resection, as evidenced by theFig. 3. The current was reduced to 1.75 mA and electrical stimulation was applied and again
clonic movements that later generalized. Iced lactated Ringer’s solution was used and the srepeated induction of seizure activity at 1.75 mA of stimulation. The
presence of both phenytoin and levetiracetam in higher levels for the
second attempted resection may have signiﬁcantly reduced the
excitability of the neurons to electrical stimulation and resulted in
much higher current (9.0 mA) requirement to elicit motor response.
From our experience using this pattern of intraoperative electrical
stimulation, patients normally exhibit motor response in the range of
2–6 mA. This patient’s response threshold was observed to increase
from a lower than expected level of 1.75 mA to a higher than usual
value of 9.0 mA in the time of one week concurrent with increasing
dosages of antiepileptic medications. One possible explanation may
be that the differing mechanisms of seizure blockade for phenytoin
and levetiracetam led to even greater depression of neuronal
excitability than would be seen with either drug independently.
The lack of intraoperative seizures in the second attempt at tumor
resection can potentially be explained by the presence therapeutic serum
levels of antiepileptic drugs. The modulatory effects of phenytoin on
membrane sodiumchannels and levetiracetamonsynaptic vesicleprotein
2Ahave a dampening effect on abnormalﬁring similar to that seenduringthe patient developed an electrographic and clinical seizure that started as focal tonic–
eizure was aborted.
Fig. 4. Although 1.5 mA didn’t result in any motor response, subsequent attempts using 1.75 mA demonstrated that this small current would repeatedly cause tonic–clonic
movements that would generalize and therefore the intraoperative mapping and attempted resection were aborted.
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the current used for mapping of the cortex and this caused the ﬁring of
neurons to become excessive leading to a generalized seizure. Under the
modulation of antiepileptic drugs, the same degree of stimulation and
increasingly higher levels of stimulation may have failed to generate
action potentials required to initiate seizure activity.
The use of perioperative dexamethasone in this patient represents
the current standard of care in patients with high grade gliomas and
brainmetastases. Glucocorticoid use has been shown to decrease pain,
nausea, and vomiting and improve overall outcomes by relieving
intracranial pressure in the perioperative period. This pressure
reduction is due to modulation of vasogenic edema that is seen in
intracranial tumors due to increased permeability of the blood brain
barrier [8]. Glucocorticoids reduce expression of inﬂammatory
cytokines and chemokines responsible for escalating the inﬂamma-
tory response and increasing the ﬂuid permeability of the blood brain
barrier. In addition, glucocorticoids may protect neurons against
glutamate toxicity that has been shown to induce seizure activity in
patients with high grade gliomas [9]. Dexamethasone is the most
commonly used glucocorticoid by neuro-oncologists and neurosur-
geons owing to its comparatively minimal mineralocorticoid activity
and possibly lower risk of infection or cognitive impairment. There
have been no previous reports of glucocorticoids inﬂuencing the
current required for intraoperative brain mapping, and current
understanding of glucocorticoid mechanisms does not predict the
existence of such interactions.
For both the initial resection attempt and follow up surgery,
propofol was used in anesthetic management. The rate of propofol
administration in each procedure ranged from 0 μg/kg/min (during
awake stimulation) to 125 μg/kg/min for a total dose of 1590 mg in
the ﬁrst procedure and 1475 mg in the second. Propofol is recognized
as having uniform depressant activity on the central nervous system.
As a result propofol may suppress neuronal ﬁring and seizure
generation by inhibiting release of excitatory neurotransmitters
[10]. Because similar doses of propofol were given in both surgical
attempts and because propofol is not administered during stimula-
tion, the observed difference in cortical response thresholds seen
cannot be attributed to the actions of propofol. To date there have
been no reports of propofol altering seizure and motor thresholds in
awake cortical and subcortical mapping procedures to the degree
observed in this case.The ﬁndings in this case confer that the antiepileptic drugs
phenytoin and levetiracetam do impact the awake craniotomy
procedure. In repeated resection attempts only 7 days apart, our
patient was observed to have increased seizure andmotor stimulation
thresholds with intraoperative cortical stimulation on the higher dose
regimen, as would be expected. The signiﬁcance of this report is in the
quantiﬁcation of a speciﬁc and reproducible increase in the motor
stimulus and seizure threshold that can be attributed to a deﬁned
intervention, that is the institution of high dose levetiracetam and
phenytoin administration. The ﬁndings in this case indicate the need
for awareness of the potential for higher current requirements in
patients preoperatively treated with high doses of antiepileptic
drugs prior to awake craniotomy procedures. In addition, this
case emphasizes the importance of conﬁrming adequate dosage of
antiepileptic drugs in patients undergoing awake craniotomies,
especially those believed to be at an increased risk of seizure
generation.
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